Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
May 2022	49	Global Markets Direct	ASDR-601535

Published: May 2022 - Pages : 49 - Publisher : Global Markets Direct - Report code : ASDR-601535

Ctcbio Inc
Sobrera Pharma AB
Sopharma AD
Suven Life Sciences Ltd